The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients.
暂无分享,去创建一个
J. Dziura | L. Fiellin | A. Justice | D. Rimland | V. Marconi | C. Gibert | M. Rodriguez‐Barradas | S. Maisto | P. O'Connor | D. Fiellin | N. Hansen | C. Cutter | K. Bryant | M. Simberkoff | R. Bedimo | E. J. Edelman
[1] Richard D Moore,et al. Heavy Alcohol Use Is Associated With Worse Retention in HIV Care , 2016, Journal of acquired immune deficiency syndromes.
[2] Brandon D. L. Marshall,et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. , 2016, Drug and alcohol dependence.
[3] K. Kraemer,et al. Number of Drinks to “Feel a Buzz” by HIV Status and Viral Load in Men , 2016, AIDS and Behavior.
[4] L. Fiellin,et al. Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics , 2016, Addiction Science & Clinical Practice.
[5] A. Raj,et al. Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection. , 2015, Journal of substance abuse treatment.
[6] F. Wurst,et al. Ethanol metabolites: their role in the assessment of alcohol intake. , 2015, Alcoholism, clinical and experimental research.
[7] J. Franck,et al. Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level. , 2015, Alcoholism, clinical and experimental research.
[8] D. Patrick,et al. Patient and provider priorities for self-reported domains of HIV clinical care , 2015, AIDS care.
[9] Alex H. S. Harris,et al. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. , 2015, Journal of substance abuse treatment.
[10] Samantha D. Outcalt,et al. Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial. , 2015, JAMA internal medicine.
[11] C. Kahler,et al. Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services , 2015, Addictive disorders & their treatment.
[12] A. O'Leary,et al. Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients. , 2014, Alcoholism, clinical and experimental research.
[13] E. Williams,et al. An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration. , 2014, Addiction.
[14] A. Justice,et al. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] P. Cuijpers,et al. Stepped care treatment delivery for depression: a systematic review and meta-analysis , 2014, Psychological Medicine.
[16] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[17] R. Rosenheck,et al. Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study. , 2014, Addictive behaviors.
[18] B. Agan,et al. The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy , 2014, Journal of acquired immune deficiency syndromes.
[19] E. Kaner,et al. The Impact of Brief Alcohol Interventions in Primary Healthcare: A Systematic Review of Reviews , 2013, Alcohol and alcoholism.
[20] R. Rosenheck,et al. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study. , 2013, Drug and alcohol dependence.
[21] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[22] K. Kraemer,et al. HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.
[23] Timothy R Sterling,et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy , 2013, AIDS.
[24] Richard D Moore,et al. Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection: A North American Cross Cohort Analysis , 2013, Journal of acquired immune deficiency syndromes.
[25] Alex H. S. Harris,et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. , 2013, Psychological services.
[26] Guido Viel,et al. Phosphatidylethanol in Blood as a Marker of Chronic Alcohol Use: A Systematic Review and Meta-Analysis , 2012, International journal of molecular sciences.
[27] B. Turner,et al. Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. , 2012, Journal of studies on alcohol and drugs.
[28] K. Kraemer,et al. Unhealthy Alcohol and Illicit Drug Use Are Associated With Decreased Quality of HIV Care , 2012, Journal of acquired immune deficiency syndromes.
[29] G. D’Onofrio,et al. A brief intervention reduces hazardous and harmful drinking in emergency department patients. , 2012, Annals of emergency medicine.
[30] V. Gruber,et al. Untreated HIV Infection Is Associated With Higher Blood Alcohol Levels , 2012, Journal of acquired immune deficiency syndromes.
[31] L. Kuller,et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] C. Torti,et al. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] B. Gazzard,et al. Increasing burden of liver disease in patients with HIV infection , 2011, The Lancet.
[34] Harold Alan Pincus,et al. Can Psychiatry Cross the Quality Chasm? Improving the Quality of Health Care For Mental and Substance Use Conditions , 2011 .
[35] F. Altice,et al. Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative , 2011, Journal of acquired immune deficiency syndromes.
[36] F. Altice,et al. Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone , 2011, Journal of acquired immune deficiency syndromes.
[37] Lei Liu,et al. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials. , 2010, Alcoholism, clinical and experimental research.
[38] J. Hahn,et al. Alcohol and HIV Disease Progression: Weighing the Evidence , 2010, Current HIV/AIDS reports.
[39] N. Petry,et al. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? , 2010, Journal of Substance Abuse Treatment.
[40] K. Covinsky,et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.
[41] M. Webb. Brief Intervention for Hazardous and Harmful Drinkers in the Emergency Department , 2009 .
[42] R. Norman,et al. HIV care providers' implementation of routine alcohol reduction support for their patients. , 2009, AIDS patient care and STDs.
[43] L. Metsch,et al. HIV-positive patients' discussion of alcohol use with their HIV primary care providers. , 2008, Drug and alcohol dependence.
[44] Declan T. Barry,et al. Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. , 2008, The American journal on addictions.
[45] A. Raj,et al. Associations Between Alcohol, Heroin, and Cocaine Use and High Risk Sexual Behaviors Among Detoxification Patients , 2007, The American journal of drug and alcohol abuse.
[46] D. Kivlahan,et al. Implementation of evidence-based alcohol screening in the Veterans Health Administration. , 2006, The American journal of managed care.
[47] K. Kraemer,et al. Intoxication Before Intercourse and Risky Sexual Behavior in Male Veterans With and Without Human Immunodeficiency Virus Infection , 2006, Medical care.
[48] A. Justice,et al. Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice. , 2006, Medical care.
[49] D. Kanouse,et al. Correlates of sex without serostatus disclosure among a national probability sample of HIV patients , 2006, AIDS and Behavior.
[50] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.
[51] David Couper,et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.
[52] Alan Y. Chiang,et al. Data Analysis of Asymmetric Structures: Advanced Approaches in Computational Statistics , 2006, Technometrics.
[53] Neil Skolnik,et al. Helping Patients Who Drink Too Much , 2005 .
[54] Joseph Conigliaro,et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. , 2005, Alcoholism, clinical and experimental research.
[55] L. Degutis,et al. Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[56] R. Saitz. Clinical practice. Unhealthy alcohol use. , 2005, The New England journal of medicine.
[57] Peter W. Dillingham,et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death , 2004, International journal of STD & AIDS.
[58] Geert Molenberghs,et al. Analyzing incomplete longitudinal clinical trial data. , 2004, Biostatistics.
[59] Julio S. G. Montaner,et al. Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 109 cells/L , 2003, Annals of Internal Medicine.
[60] D. Kanouse,et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. , 2003, American journal of public health.
[61] B. Yip,et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up , 2002, AIDS.
[62] K. Fletcher,et al. Handbook of Psychiatric Measures , 2002 .
[63] K. Kraemer,et al. Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. , 2001, Journal of studies on alcohol.
[64] L. Sobell,et al. Stepped care as a heuristic approach to the treatment of alcohol problems. , 2000, Journal of consulting and clinical psychology.
[65] Michael B. First,et al. Handbook of Psychiatric Measures , 2000 .
[66] P. O'Connor,et al. Screening for alcohol problems in primary care: a systematic review. , 2000, Archives of internal medicine.
[67] D. Kivlahan,et al. The AUDIT Alcohol consumption questions (AUDIT-C) : An effective brief screening test for problem drinking , 1998 .
[68] K. Barry,et al. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. , 1997, JAMA.
[69] D. Metzger,et al. The Fifth Edition of the Addiction Severity Index. , 1992, Journal of substance abuse treatment.
[70] A. Alterman,et al. A New Measure of Substance Abuse Treatment Initial Studies of the Treatment Services Review , 1992, The Journal of nervous and mental disease.
[71] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.
[72] T D Koepsell,et al. A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation , 1988, Medical care.
[73] A. Justice,et al. Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment , 2015 .
[74] J. Crippa,et al. Psychometric properties of the Fagerström Test for Nicotine Dependence. , 2009, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[75] R. Norman,et al. HIV Care Providers' Role Legitimacy as Supporters of Their Patients' Alcohol Reduction. , 2009, The open infectious diseases journal.
[76] F. Fantozzi,et al. Helping patients who drinks too much. A Clinician’s Guide , 2006 .
[77] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[78] D. Kivlahan,et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. , 1998, Archives of internal medicine.
[79] C. Brandt,et al. Application of Technology: Managing Attribute-Value Clinical Trials Data Using the ACT/DB Client-Server Database System , 1998, J. Am. Medical Informatics Assoc..
[80] Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. , 1997, Journal of studies on alcohol.